产品详情
靶点信息
JAK2 (Cell-free assay) | RET (Cell-free assay) | FLT3 (Cell-free assay) | JAK3 (Cell-free assay) | |
6 nM | 17 nM | 25 nM | 169 nM |
In vitro (25°C) | DMSO | 94 mg/mL (184.42 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 1% DMSO+30% polyethylene glycol+1% Tween 80 | 11 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 19.62 mL | 98.1 mL | 196.21 mL |
0.5 mM | 3.92 mL | 19.62 mL | 39.24 mL |
1 mM | 1.96 mL | 9.81 mL | 19.62 mL |
5 mM | 0.39 mL | 1.96 mL | 3.92 mL |
*The above data is based on the productmolecular weight 509.67. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A11180 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 509.67 |
Formula | C26H35N7O2S |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 936091-14-4 |
Synonyms | TG-101209 |
SMILES | CN1CCN(CC1)C2=CC=C(C=C2)NC3N=C(NC4=CC(=CC=C4)S(=O)(=O)NC(C)(C)C)C(C)=CN=3 |
产品标签
Product Questions
Product Questions
SGI-1776 (free base)
SGI-1776 (free base)是Pim1的一种新型ATP竞争性抑制剂,在无细胞试验中的IC50为7 nM,选择性是Pim2和Pim3的50倍和10…
Pexidartinib (PLX3397)
Pexidartinib (PLX3397)是KIT,CSF1R和FLT3的小分子酪氨酸激酶(RTK)抑制剂,具有潜在的抗肿瘤活性。
VX-680 (MK-0457, Tozasertib)
VX-680 (MK-0457,Tozasertib)是一种有效的选择性Aurora激酶小分子抑制剂。
BMS-911543
BMS-911543是一种有效的、选择性JAK2小分子抑制剂。
Filgotinib
Filgotinib是一种选择性的JAK1抑制剂,对于JAK1,JAK2,JAK3和TYK2的IC50分别为10 nM,28 nM,810 nM和116 nM。